Pamidronate: a novel treatment for the SAPHO syndrome?
Open Access
- 1 February 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 41 (2) , 231-233
- https://doi.org/10.1093/rheumatology/41.2.231-a
Abstract
Sir, The SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis and osteitis) was first described by Chamot et al. in 1987 [1]. It can occur at any age but usually appears between childhood and middle age. The most troublesome symptom is bone pain, which most often affects the anterior chest wall. Dermatological features include pustulosis of the palms and soles, pustular psoriasis, acne conglobata or fulminans and hydradenitis suppurativa [2].Keywords
This publication has 4 references indexed in Scilit:
- Imaging findings of sternal abnormalitiesEuropean Radiology, 1997
- Acquired hyperostosis syndrome — AHYS — (sternocostoclavicular hyperostosis, pustulotic arthro-osteitis, SAPHO-syndrome): Bone scintigraphy of the anterior chest wallClinical Rheumatology, 1997
- Osseous Manifestations of SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis) SyndromeThe American Journal of Surgical Pathology, 1996
- Calcitonin treatment for intersternocostoclavicular ossification: clinical experience in two cases.Annals of the Rheumatic Diseases, 1991